© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
October 22, 2021
October 20, 2021
Higher use of 7 major antibiotics in hospitals is corelated with higher rates of Clostridioides difficile infection.
October 13, 2021
For the first time, investigators proved that a higher presence of Clostridioides difficile bacteria and toxins cause a more severe infection.
CDI remains an urgent public health threat and continues to be the most frequent cause of diarrhea among hospitalized patients and overall hospital-acquired infection in the United States.
October 08, 2021
A global study of C. difficile isolates worldwide found a very high prevalence of the bacteria on shoe soles.
September 22, 2021
With fecal microbiota transplants (FMT) becoming a potential emerging therapy for these patients, here are some aspects to consider when treating.
September 01, 2021
Purified nisin is effective at killing Clostridioides difficile, a recent ex vivo study demonstrated, opening up the potential to use the bacteriocin as a treatment.
August 25, 2021
August 01, 2021
What are the efforts being made with antibiotic stewardship and treatments, and what areas in clinical care do medical professionals want to see improvements.
July 09, 2021
The company’s RBX2660, administered as a single dose, demonstrated superiority over standard of care for reducing Clostridioides difficile infection (CDI) recurrence.